IMO Health wins 2025 Best in Business Awards for data analytics and RCM

Learn why our industry-leading clinical terminology and dedication to data quality earned IMO Health two Best in Business Awards from Modern Healthcare.
Published
Written by
Picture of Megan Hillgard
Sr. Marketing Campaign Manager

IMO Health is proud to be recognized by Modern Healthcare with two Best in Business Awards in the categories of data analytics and revenue cycle management (RCM). These awards celebrate our continued commitment to delivering measurable impact through terminology-driven innovation, domain-specific clinical AI, and solutions designed to improve both care delivery and financial performance.

IMO Health’s trusted clinical intelligence continues to power results across the healthcare ecosystem. “For more than 30 years, IMO Health has propelled the healthcare industry forward, equipping organizations with data they can rely on to work smarter and innovate faster,” said Ann Barnes, CEO of IMO Health. “I’m so proud of this team and all they’ve done to get us here.”

IMO Health’s award-winning data analytics and RCM solutions help organizations:

  • Align free text to clinical intent with 92% accuracy
  • Reduce diagnostic errors and revenue leakage by up to 45%
  • Outperform leading GPT models by 67% in ICD-10-CM mapping accuracy
  • Reduce claim denials by 67% and achieve a 10x annualized ROI

These wins highlight IMO Health’s ongoing dedication to its customers. Every solution we build is guided by the goal of helping organizations deliver better care, simplify workflows, and optimize revenue to achieve meaningful, lasting outcomes.

You can read the full press release here.

To learn more about IMO Health’s solutions, explore our portfolio or schedule a demo with one of our experts.

Related Content

Latest Resources​

IMO Health wins 2026 MedTech Breakthrough Award for Best Healthcare Big Data Solution, recognizing innovation in AI-ready clinical data.
RPM coding has continued to evolve, with updated codes scheduled to take effect in 2026. Here’s what’s changing and what it means
How better clinical data, AI, and real-world evidence can accelerate rare disease diagnosis, improve trial design, and spark faster drug development.
ICYMI: BLOG DIGEST

The latest insights and expert perspectives from IMO Health

In your inbox, twice per month.